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Prostate and bladder
Gold seeds as ﬁducial markers for bladder localization during radiotherapy
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Introduction. Target localization and veriﬁcation of the treatment position is important for the accurate delivery of conformal
radiotherapy. The bladder in particular is a deformable structure whose shape and position continually varies throughout a
course of radiation treatment as a result of bladder ﬁlling. We report a case in which we used a novel technique in of organ
localization using gold seeds as ﬁducial markers that are implanted into the bladder using an applicator that is passed through
a rigid cystoscope.
Materials and methods. The procedure was performed in one patient with macroscopic residual disease in the CT, Cystoscopy with
positive biopsy after TUR. Under sedation, ﬁve seeds were implanted, 3 around of the tumour and 2 in the contralateral wall, after
sterilization with manually pre-loaded into the needle using an aseptic technique before the applicator was passed through the
cystoscope. The needle of the applicator was inserted into the bladder wall under direct visualization and the seeds implanted
via the use of a guidewire operated manually. With curative intention, after chemotherapy the treatment was performed using
3DCRT technique with high-energy photons from a linear accelerator with multiple ﬁelds with multileaf shaped coplanar and
isocentric. He was treated supine with the bladder empty into the ﬁrst and second phase and the third phase full bladder was
driven veriﬁcation and adjustments daily portal imaging with gold markers. Received a total dose of 61.2Gy in 1.8Gy fractions.
Treatment was uneventful. As remarkable toxicity intense dysuria and cystitis G2.
Conclusion. The use of ﬁducial markers for the guidance of radiation therapy for bladder cancer is safe and feasible and could
enhance the accuracy efﬁcacy of radiotherapy for this patients.
http://dx.doi.org/10.1016/j.rpor.2013.03.683
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Purpose. Low dose rate (LDR) prostate brachytherapy is an accepted, effective and safe therapy for localized prostate cancer. One
the other hand, treatment with temporary high dose rate (HDR) brachytherapy with 192-Ir as monotherapy has a number of
advantages compared to LDR. We analyze the technique followed in the Group of patients treated within the planned trial.
Methods and Material. From a biologic perspective, the low prostate cancer / favors a large dose per fraction in terms of cancer
control. At the same time, the / of the rectum and bladder favors larger doses per fraction to increase the therapeutic window,
thus improving controlwhile limiting toxicity. BesidesHDRbrachytherapy asmonotherapyhas anumber of advantages compared
to LDR. Medical staff are completely free from radiation exposure, no radioactivity or material is left in the body of the patient
after treatment, the overall treatment time is decreased from many months with LDR to several minutes with HDR and improves
the radiation dose distribution, secondary to the ability to control the source position accurately and vary the source dwell time
during treatment.
Results. All patients received one implant and one fraction of HDR. Fraction dosewas 20.5 Gy. Brachytherapy procedureswere done
under spinal anesthesia with the patient in the lithotomy position. A Foley catheter was placed. The needles were positioned by
transperineal placement under real time TRUS guidance using a template. Axial cross-sections were captured in 2mm steps and
transferred to the Treatment Planning Software. Prostate gland, normal structures (urethra and rectum) and needle positions
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